ClinicalTrials.Veeva

Menu

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 3

F

Fundacin Biomedica Galicia Sur

Status

Completed

Conditions

Colorectal Cancer

Treatments

Diagnostic Test: PolyDeep assisted high definition colonoscopy (CAD system) in Adenoma Detection Rate
Diagnostic Test: High definition colonoscopy (standard colonoscopy) in Adenoma Detection Rate

Study type

Interventional

Funder types

Other

Identifiers

NCT05513261
PolyDeep Advance 3.0

Details and patient eligibility

About

This study is a clinical validation of PolyDeep, a computer-aided polyp detection (CADe) and characterization (CADx) system. PolyDeep Advance 3 is a multicentric randomized clinical trial comparing high definition colonoscopy with PolyDeep assisted high definition colonoscopy. The hypothesis of the study is that the PolyDeep assisted colonoscopy increases the Adenoma Detection Rate (ADR).

Full description

Colorectal cancer (CRC) is the most frequently cancer in western world. A fundamental tool for detection and prevention is the colonoscopy. The detection and endoscopic resection of colorectal polyps, the precursor lesion of CRC, can reduce CRC incidence and mortality. Adenoma Detection Rate is the most used endoscopic quality indicator. The improvement of this indicator is related to the reduction of postcolonoscopy CRC incidence and mortality.

Colorectal polyp diagnosis is based on endoscopic resection and histological analysis. An accurate optical diagnosis could avoid histological lesion of smaller lesions, reducing the costs associated with histological diagnosis. The NICE (NBI International Colorectal Endoscopic) Classification has proposed use high definition endoscopes that have Narrow Band Imaging (NBI). However, NICE must be used by endoscopists who are sufficiently prepared and who have overcome the learning curve. Therefore, optical histology diagnosis with high accuracy independently of the center and the endoscopist is necessary.

Computer Aid Diagnosis (CAD) systems based on Artificial Intelligence are experiencing exponential development in the field of medical image analysis. The development of the CAD system is based on the creation of large databases of endoscopic images and/or videos, on the training, development and validation of diagnostic algorithms in such databases and, finally, on prospective clinical validation in patients undergoing colonoscopy. The goal of CAD systems in colonoscopy is double. First, the CAD system aims to increase the detection of polyps (CADe) in general, and of adenomas and serrated lesions in particular. The second objective is to characterize (CADx) the histology of detected lesion.

PolyDeep CAD is a functional prototype. This CAD system is capable of detecting, locating and classifying colorectal polyps. In vivo validation data shows that PolyDeep has high diagnostic accuracy for polyp identification and that this accuracy can be accommodated. The aim of PolyDeep advance 3 is to compare Adenoma Detection Rate differences in a randomized clinical trial. The investigators will compare the Adenoma Detection Rate between high definition colonoscopy and PolyDeep assisted high definition colonoscopy, both in CRC screening and surveillance.

Enrollment

857 patients

Sex

All

Ages

40 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First diagnostic colonoscopy performed after a positive fecal immunochemical test performed within the CRC screening program.
  • Surveillance after resection of colorectal adenomas
  • Acceptance after reading the information sheet and signing informed consent.

Exclusion criteria

  • Colonoscopies with insufficient intestinal cleansing (Boston Bowel Preparation Scale <6 or <2 in any of the evaluated segments).
  • Incomplete colonoscopy without cecal intubation.
  • Previous CRC
  • Previous colonic resection.
  • Hereditary CRC syndromes
  • Serrated polyposis syndrome

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

857 participants in 2 patient groups

Control arm: High definition colonoscopy
Other group
Description:
Diagnostic test: Standard colonoscopy
Treatment:
Diagnostic Test: High definition colonoscopy (standard colonoscopy) in Adenoma Detection Rate
PolyDeep assisted high definition colonoscopy
Experimental group
Description:
Diagnostic test: PolyDeep
Treatment:
Diagnostic Test: PolyDeep assisted high definition colonoscopy (CAD system) in Adenoma Detection Rate

Trial contacts and locations

3

Loading...

Central trial contact

Miguel Reboiro Jato, PhD; Joaquín Cubiella Fernandez, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems